expanding Globus Medical's reach into the musculoskeletal market, particularly in neuromodulation technology and chronic pain treatment solutions. Management reaffirmed 2025 revenue guidance of $2 ...

Globus Medical, Inc., a medical device company ... such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral ...

Globus Medical will hold a teleconference to ... unless the underlying item has a materially different tax treatment, in which case the estimated tax rate applicable to the adjustment is used.

On Wednesday, 2291 stocks advanced, 1685 declined and 139 remained unchanged on Bombay Stock Exchange with advance decline ...

the day after the spine treatment tech company released an after-hours Q1 earnings report that missed The Street. [Find out more about Globus Medical and other major orthopedic device companies in ...

Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company ...

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s what to look for. Globus Medical beat analysts’ revenue expectations ...

Globus Medical reported its financial results for Q1 2025, revealing a miss on both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.68, falling short of the ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of ...